RT Journal Article
T1 A Delphi Study on the Management of Neuropathic Cancer Pain in Spain: The DOLNEO Study.
A1 Pérez-Hernández, Concepción
A1 Cánovas, María Luz
A1 Carmona-Bayonas, Alberto
A1 Escobar, Yolanda
A1 Margarit, César
A1 Mulero Cervantes, Juan Francisco
A1 Quintanar, Teresa
A1 Serrano Alfonso, Ancor
A1 Virizuela, Juan
K1 cancer-related neuropathic pain
K1 consensus
K1 diagnosis
K1 prevalence
K1 treatment
AB The objectives of this project were to assess the current situation and management of cancer-related neuropathic pain (CRNP) in Spain and to provide specific recommendations for the assessment, diagnosis and treatment of CRNP using a Delphi methodology. This was a qualitative study that followed a Delphi methodology using a questionnaire with 56 statements that were grouped into 5 areas related to CRNP: prevalence and impact, pathophysiology, assessment and diagnosis, specific syndromes, treatment, and multidisciplinary approach. Based on the responses, the scientific committee prepared an algorithm and a recommended pathway for the management of CRNP. Seventy-nine physicians attended the meeting and completed the questionnaire. Consensus was reached for all statements relating to the prevalence and impact of CRNP. However, the perceptions of specialists from palliative care of the frequency and impact of CRNP differed from those of other specialists. A high degree of consensus was reached for all statements concerning the assessment and diagnosis of CRNP. Regarding specific syndromes, the only statement with a lack of consensus was that on the frequency of NP in patients undergoing radiotherapy. There were some disagreements regarding the multidisciplinary approach and referral criteria for the management of NP. Our results show a large degree of agreement on the assessment, diagnosis and treatment of cancer-related neuropathic pain among the specialists involved in its management. There were, however, some disagreements regarding the multidisciplinary approach and referral criteria for the management of neuropathic pain.
SN 1178-7090
YR 2022
FD 2022-08-02
LK http://hdl.handle.net/10668/20473
UL http://hdl.handle.net/10668/20473
LA en
DS RISalud
RD Apr 6, 2025